Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membrane phospholipids and lipopolysaccharides (LPS) are fundamental structural elements of the bacterial cell envelope that ensure cellular stability and serve as a protective barrier against external threats [NIH/NCBI, 2022]. Lipopolysaccharides, primarily found in the outer membrane of Gram-negative bacteria, consist of a hydrophobic Lipid A anchor, a core oligosaccharide, and an O-antigen polysaccharide [NIH/NCBI, 2022]. Lipid A is specifically recognized by the host immune system as a potent endotoxin, triggering inflammatory cascades via Toll-like receptor 4 [NIH/NCBI, 2022]. Phospholipids form the lipid bilayer in both Gram-positive and Gram-negative bacteria, maintaining the electrochemical gradients essential for ATP synthesis and nutrient transport [Nature Reviews Microbiology, 2021]. These molecules are the primary targets for several "last-resort" antibiotics, such as polymyxins and daptomycin [StatPearls, 2023]. Polymyxins act by binding to the negatively charged Lipid A of LPS, displacing stabilizing divalent cations and causing membrane leakage [StatPearls, 2023]. Daptomycin targets phosphatidylglycerol in Gram-positive membranes, leading to calcium-dependent insertion and rapid depolarization [StatPearls, 2023]. While highly effective against multidrug-resistant pathogens, drugs targeting these components often carry significant risks of nephrotoxicity and neurotoxicity due to potential interactions with host cell membranes [StatPearls, 2023]. The release of large amounts of LPS during treatment can also lead to systemic inflammatory responses like the Jarisch-Herxheimer reaction [NIH/NCBI, 2022]. Understanding these targets is crucial for developing new strategies to combat antibiotic resistance in clinical settings [Nature Reviews Microbiology, 2021].
Disruption of membrane integrity through binding to Lipid A or phospholipids, leading to displacement of divalent cations, pore formation, and membrane depolarization [StatPearls, 2023].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane phospholipids and lipopolysaccharides (LPS/PL).